Liver disease: Eva’s story | Action Medical Research

Eva has a rare liver disease called progressive familial intrahepatic cholestasis type 3 (PFIC3), which over time causes severe damage. A liver transplant is the only curative treatment, but this is a major operation and has a risk of complications – and there is a shortage of donor livers. Action Medical Research is funding work to develop gene therapy for PFIC3. If successful, this could ultimately lead to a safer and better treatment option for children with this life-threatening condition.

Read Eva’s story: https://action.org.uk/research/family-stories/eva-rare-liver-disease
----
http://www.action.org.uk

http://twitter.com/actionmedres
http://www.facebook.com/actionmedres